Reported September 20, 2026: 'Australia's Telix Pharma Agrees To Buy Germany's ITM Isotope For About $1.65B'

Telix Pharma, an Australian company, has announced its agreement to acquire Germany's ITM Isotope for approximately $1.65 billion. This strategic move aims to strengthen Telix's position in the radiopharmaceutical market. The acquisition is expected to enhance Telix's capabilities and product offerings in the sector.